Borosil Scientific Ltd

Borosil Scientific Ltd has responded to an email from the BSE dated June 30, 2026, regarding a recent increase in the stock's price and volume. The company stated that it has not withheld any material information or events that require disclosure under SEBI regulations. Borosil Scientific clarified that the observed market behavior is purely driven by market forces and not due to any undisclosed material information. The company has requested the BSE to take this clarification on record.

Borosil Scientific Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 01, 2026, until 48 hours after the declaration of the Un-audited Financial Results (Standalone & Consolidated) for the quarter ending June 30, 2026. The specific date for the Board Meeting to approve these results will be communicated separately.

Borosil Scientific Ltd's Nomination and Remuneration Committee approved the grant of 18,700 stock options under its Employee Stock Option Scheme on May 20, 2026. Each option allows the holder to apply for one equity share of Re.1 each. The options were granted at ₹108 per option, a ~10% discount on the market price. The options vest over four years, with 25% vesting annually. The exercise period is 5 years from the vesting date.

Borosil Scientific Ltd has re-appointed Mr. Vinayak Madhukar Patankar as Whole-time Director & CEO for a period of 3 years effective from December 2, 2026, subject to shareholder approval. The board also approved audited financial statements and results for the year ended March 31, 2026, and authorized seeking shareholder approval to raise up to ₹250 crores. Mr. Sanjay Gupta resigned as Company Secretary and Compliance Officer, and Mr. Ramavtar Sharma was appointed in his place, effective May 21, 2026.

The Board of Directors of Borosil Scientific Ltd approved the audited financial statements and results (standalone & consolidated) for the year ended March 31, 2026. They authorized seeking shareholder approval to raise up to ₹250 crores through various methods. Mr. Vinayak Madhukar Patankar was re-appointed as Whole-time Director & CEO for 3 years. Mr. Sanjay Gupta resigned as Company Secretary and Compliance Officer, and Mr. Ramavtar Sharma was appointed in his place, effective May 21, 2026.

Borosil Scientific Ltd's Board of Directors approved the audited financial statements (standalone & consolidated) and results for the year ended March 31, 2026. They also approved seeking shareholder approval to raise up to ₹250 crores through various methods. Mr. Vinayak Madhukar Patankar was re-appointed as Whole-time Director & CEO for 3 years. Mr. Sanjay Gupta resigned as Company Secretary & Compliance Officer, and Mr. Ramavtar Sharma was appointed in his place.

Borosil Scientific Ltd has scheduled a Board of Directors meeting on May 20, 2026, to consider and approve the audited financial results (standalone & consolidated) for the quarter and financial year ended March 31, 2026. The board will also seek shareholders’ approval for raising funds through various modes, including Qualified Institutional Placement, further public offer, or Foreign Currency Convertible Bonds. The trading window is closed from April 1, 2026, until 48 hours after the results are declared.

Shreevar Kheruka, a Promoter and Non-Executive Director of Borosil Scientific Ltd, has acquired 0.47% (4,15,426 shares) of the company's total share capital and 0.46% (4,15,426 shares) of the total diluted share capital through open market purchases. This acquisition took place between March 09, 2026, and March 30, 2026. After the acquisition, Kheruka's total holding stands at 68.27% (6,07,26,838 shares) of the total share capital and 67.08% (6,07,26,838 shares) of the total diluted share capital.

Borosil Scientific Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. The trading window will remain closed from April 01, 2026 till 48 hours after the declaration of Audited Financial Results for the quarter and financial year ending March 31, 2026. The date of the Board Meeting for the declaration of financial results will be intimated in due course. Designated persons and their immediate relatives are prohibited from entering or dealing in any transaction of shares of Borosil Scientific Limited during the trading window closure period.

Borosil Scientific Ltd has granted 6,700 stock options under the 'Borosil Scientific Limited - Employee Stock Option Scheme'. The options have been granted at a price of Rs. 95 per option, which is a discount of approximately 10% on the market price. The options will vest in the following manner: 25% after the first anniversary from the date of grant, 25% after the second anniversary, 25% after the third anniversary, and 25% after the fourth anniversary. This decision was made at a meeting of the Nomination and Remuneration Committee on February 11, 2026.